Elucidation of mechanisms of ceftazidime resistance among clinical isolates of pseudomonas aeruginosa by using genomic data

Abstract

Ceftazidime is one of the few cephalosporins with activity against Pseudomonas aeruginosa. Using whole-genome comparative analysis, we set out to determine the prevalent mechanism(s) of resistance to ceftazidime (CAZ) using a set of 181 clinical isolates. These isolates represented various multilocus sequence types that consisted of both ceftazidime-susceptible and -resistant populations. A presumptive resistance mechanism against ceftazidime was identified in 88% of the nonsusceptible isolates using this approach.